160 related articles for article (PubMed ID: 28743716)
1. How I monitor long-term and late effects after blood or marrow transplantation.
Bhatia S; Armenian SH; Landier W
Blood; 2017 Sep; 130(11):1302-1314. PubMed ID: 28743716
[TBL] [Abstract][Full Text] [Related]
2. Burden of Long-Term Morbidity Borne by Survivors of Acute Myeloid Leukemia Treated With Blood or Marrow Transplantation: The Results of the BMT Survivor Study.
Armenian SH; Chen Y; Hageman L; Wu J; Landier W; Bosworth A; Francisco L; Schlichting E; Bhatia R; Salzman D; Wong FL; Weisdorf DJ; Forman SJ; Arora M; Bhatia S
J Clin Oncol; 2022 Oct; 40(28):3278-3288. PubMed ID: 35731989
[TBL] [Abstract][Full Text] [Related]
3. Late-occurring venous thromboembolism in allogeneic blood or marrow transplant survivors: a BMTSS-HiGHS2 risk model.
Gangaraju R; Chen Y; Hageman L; Wu J; Francisco L; Kung M; Weisdorf DJ; Forman SJ; Arora M; Armenian SH; Bhatia S
Blood Adv; 2021 Oct; 5(20):4102-4111. PubMed ID: 34461633
[TBL] [Abstract][Full Text] [Related]
4. Health care utilization by long-term survivors of blood or marrow transplantation-A Bone Marrow Transplant Survivor Study report.
Oliver MM; Meng Q; Hageman L; Landier W; Balas N; Ross E; Francisco L; Bosworth A; Te HS; Wong FL; Bhatia R; Forman SJ; Armenian SH; Weisdorf DJ; Bhatia S
Cancer; 2024 Mar; 130(5):803-815. PubMed ID: 37880912
[TBL] [Abstract][Full Text] [Related]
5. Assessment of Late Mortality Risk After Allogeneic Blood or Marrow Transplantation Performed in Childhood.
Holmqvist AS; Chen Y; Wu J; Battles K; Bhatia R; Francisco L; Hageman L; Kung M; Ness E; Parman M; Salzman D; Wadhwa A; Winther JF; Rosenthal J; Forman SJ; Weisdorf DJ; Armenian SH; Arora M; Bhatia S
JAMA Oncol; 2018 Dec; 4(12):e182453. PubMed ID: 30054602
[TBL] [Abstract][Full Text] [Related]
6. Burden of Morbidity after Allogeneic Blood or Marrow Transplantation for Inborn Errors of Metabolism: A BMT Survivor Study Report.
Wadhwa A; Chen Y; Hageman L; Schlichting E; Funk E; Hicks J; Balas N; Siler A; Wu J; Francisco L; Holmqvist A; Gupta A; Lund T; Orchard PJ; Armenian S; Arora M; Bhatia S
Transplant Cell Ther; 2022 Mar; 28(3):157.e1-157.e9. PubMed ID: 34879288
[TBL] [Abstract][Full Text] [Related]
7. Venous Thromboembolism in Autologous Blood or Marrow Transplantation Survivors: A Report from the Blood or Marrow Transplant Survivor Study.
Gangaraju R; Chen Y; Hageman L; Wu J; Francisco L; Battles K; Kung M; Ness E; Parman M; Weisdorf DJ; Forman SJ; Arora M; Armenian SH; Bhatia S
Biol Blood Marrow Transplant; 2019 Nov; 25(11):2261-2266. PubMed ID: 31278995
[TBL] [Abstract][Full Text] [Related]
8. Trends in Late Mortality and Life Expectancy After Allogeneic Blood or Marrow Transplantation Over 4 Decades: A Blood or Marrow Transplant Survivor Study Report.
Bhatia S; Dai C; Landier W; Hageman L; Wu J; Schlichting E; Siler A; Funk E; Hicks J; Bosworth A; Te HS; Francisco L; Bhatia R; Salzman D; Goldman FD; Forman SJ; Weisdorf DJ; Wong FL; Arora M; Armenian SH
JAMA Oncol; 2021 Nov; 7(11):1626-1634. PubMed ID: 34499078
[TBL] [Abstract][Full Text] [Related]
9. A comparison of related donor peripheral blood and bone marrow transplants: importance of late-onset chronic graft-versus-host disease and infections.
Anderson D; DeFor T; Burns L; McGlave P; Miller J; Wagner J; Weisdorf D
Biol Blood Marrow Transplant; 2003 Jan; 9(1):52-9. PubMed ID: 12533742
[TBL] [Abstract][Full Text] [Related]
10. Lost in transition: the essential need for long-term follow-up clinic for blood and marrow transplantation survivors.
Hashmi S; Carpenter P; Khera N; Tichelli A; Savani BN
Biol Blood Marrow Transplant; 2015 Feb; 21(2):225-32. PubMed ID: 24999225
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal trajectory of frailty in blood or marrow transplant survivors: Report from the Blood or Marrow Transplant Survivor Study.
Arora M; Chen Y; Wu J; Hageman L; Ness E; Kung M; Francisco L; Bosworth A; Weisdorf DJ; Forman SJ; Landier W; Pamukçuoğlu M; Armenian SH; Wong FL; Bhatia S
Cancer; 2021 Mar; 127(5):794-800. PubMed ID: 33206383
[TBL] [Abstract][Full Text] [Related]
12. Adherence to cancer screening guidelines in Australian survivors of allogeneic blood and marrow transplantation (BMT).
Dyer G; Larsen SR; Gilroy N; Brice L; Greenwood M; Hertzberg M; Kabir M; Brown L; Hogg M; Huang G; Moore J; Gottlieb D; Kwan J; Tan J; Ward C; Kerridge I
Cancer Med; 2016 Jul; 5(7):1702-16. PubMed ID: 27108674
[TBL] [Abstract][Full Text] [Related]
13. Long-term Follow-up of Hematopoietic Stem Cell Transplant Survivors: A Focus on Screening, Monitoring, and Therapeutics.
Saunders IM; Tan M; Koura D; Young R
Pharmacotherapy; 2020 Aug; 40(8):808-841. PubMed ID: 32652612
[TBL] [Abstract][Full Text] [Related]
14. Health and functional status of long-term survivors of bone marrow transplantation. EBMT Working Party on Late Effects and EULEP Study Group on Late Effects. European Group for Blood and Marrow Transplantation.
Duell T; van Lint MT; Ljungman P; Tichelli A; Socié G; Apperley JF; Weiss M; Cohen A; Nekolla E; Kolb HJ
Ann Intern Med; 1997 Feb; 126(3):184-92. PubMed ID: 9027268
[TBL] [Abstract][Full Text] [Related]
15. Late complications in blood and marrow transplant survivors.
Majhail NS
Minn Med; 2010 Oct; 93(10):45-9. PubMed ID: 21140762
[TBL] [Abstract][Full Text] [Related]
16. Risk of venous thromboembolism in patients with non-Hodgkin lymphoma surviving blood or marrow transplantation.
Gangaraju R; Chen Y; Hageman L; Wu J; Francisco L; Kung M; Ness E; Parman M; Weisdorf DJ; Forman SJ; Arora M; Armenian SH; Bhatia S
Cancer; 2019 Dec; 125(24):4498-4508. PubMed ID: 31469420
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcome and late effects in patients transplanted with mobilised blood or bone marrow: a randomised trial.
Friedrichs B; Tichelli A; Bacigalupo A; Russell NH; Ruutu T; Shapira MY; Beksac M; Hasenclever D; Socié G; Schmitz N
Lancet Oncol; 2010 Apr; 11(4):331-8. PubMed ID: 20117965
[TBL] [Abstract][Full Text] [Related]
18. Reduced-intensity conditioning for the treatment of malignant and life-threatening non-malignant disorders.
Slavin S; Aker M; Shapira MY; Resnick I; Bitan M; Or R
Clin Transpl; 2003; ():275-82. PubMed ID: 15387119
[TBL] [Abstract][Full Text] [Related]
19. Long-term treatment burden following allogeneic blood and marrow transplantation in NSW, Australia: a cross-sectional survey.
McErlean G; Brice L; Gilroy N; Kabir M; Greenwood M; Larsen SR; Moore J; Gottlieb D; Hertzberg M; Brown L; Hogg M; Huang G; Ward C; Kerridge I
J Cancer Surviv; 2022 Apr; 16(2):432-444. PubMed ID: 33813667
[TBL] [Abstract][Full Text] [Related]
20. Impact of prophylactic donor leukocyte infusions on mixed chimerism, graft-versus-host disease, and antitumor response in patients with advanced hematologic malignancies treated with nonmyeloablative conditioning and allogeneic bone marrow transplantation.
Dey BR; McAfee S; Colby C; Sackstein R; Saidman S; Tarbell N; Sachs DH; Sykes M; Spitzer TR
Biol Blood Marrow Transplant; 2003 May; 9(5):320-9. PubMed ID: 12766882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
